| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.986 | 629 | 4 | 2001 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.993 | 418 | 1 | 2000 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.990 | 194 | 5 | 2003 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.984 | 190 | 7 | 1995 | 2020 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.987 | 149 | 0 | 1997 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.980 | 101 | 5 | 1992 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.100 | None | 0.940 | 100 | 14 | 1992 | 2020 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.930 | 71 | 0 | 2005 | 2019 | ||||||||
|
bromodomain containing 4 | 0.446 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 67 | 0 | 2011 | 2020 | ||||||||
|
aminopeptidase puromycin sensitive | 0.519 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.954 | 65 | 0 | 1999 | 2019 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.967 | 61 | 4 | 2001 | 2020 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 | 0.504 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.982 | 56 | 0 | 2002 | 2020 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.981 | 52 | 2 | 1991 | 2019 | ||||||||
|
histone deacetylase 6 | 0.465 | 0.846 | 1.00 |
|
group | 0.100 | None | 1.000 | 51 | 0 | 2008 | 2020 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.961 | 51 | 0 | 1999 | 2020 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.976 | 42 | 0 | 2004 | 2019 | ||||||||
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.950 | 40 | 1 | 2007 | 2020 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.975 | 40 | 0 | 1994 | 2019 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 40 | 0 | 2001 | 2019 | ||||||||
|
patched 1 | 0.398 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 35 | 0 | 1997 | 2020 | ||||||||
|
metastasis associated 1 | 0.547 | 0.692 | 1.00 |
|
group | 0.100 | None | 0.879 | 33 | 0 | 2002 | 2020 | ||||||||
|
jagged canonical Notch ligand 1 | 0.429 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 30 | 0 | 2009 | 2020 | ||||||||
|
lysine methyltransferase 2D | 0.465 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 30 | 1 | 1999 | 2020 | ||||||||
|
zinc finger E-box binding homeobox 2 | 0.471 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 30 | 0 | 2004 | 2019 | ||||||||
|
WNK lysine deficient protein kinase 1 | 0.416 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.963 | 27 | 0 | 1995 | 2020 |